WEST PHARMACEUTICAL SERVICES INC (WST) closed fiscal year 2025 with a gross margin of 35.9 % and a net margin of 16.1 %.
WEST PHARMACEUTICAL SERVICES INC (WST) closed fiscal year 2025 with a gross margin of 35.9 % and a net margin of 16.1 %. The same year shows an EBITDA margin of 24.6 % and an EBIT margin of 19.0 %. The free cash flow margin was 15.3 %. Against the previous year the gross margin moved +1.4 pp and the net margin −1.0 pp. Across the period the gross margin ranges between 28.5 % in 2011 and 41.5 % in 2021. The series covers 18 fiscal years, from 2008 to 2025. Margins are expressed as a percentage of net revenue and are derived from the same figures as the income statement, taken from as-reported SEC EDGAR filings, with no restatements or adjustments of our own.
Fiscal year end: December
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin (%) | 28.79 % | 28.76 % | 28.80 % | 28.46 % | 30.61 % | 31.77 % | 31.50 % | 32.56 % | 33.23 % | 32.07 % | 31.76 % | 32.92 % | 35.76 % | 41.52 % | 39.36 % | 38.28 % | 34.51 % | 35.91 % |
| EBITDA margin (%) | 17.57 % | 15.69 % | 14.84 % | 15.54 % | 16.74 % | 18.09 % | 19.14 % | 15.61 % | 18.95 % | 20.17 % | 20.07 % | 21.74 % | 24.03 % | 30.89 % | 29.60 % | 27.57 % | 25.07 % | 24.60 % |
| EBIT margin (%) | 11.81 % | 9.24 % | 8.21 % | 9.19 % | 10.67 % | 11.87 % | 12.80 % | 9.19 % | 12.93 % | 14.12 % | 13.99 % | 16.12 % | 18.95 % | 26.57 % | 25.43 % | 22.92 % | 19.70 % | 19.03 % |
| Net margin (%) | 8.18 % | 6.88 % | 5.91 % | 6.33 % | 6.37 % | 8.21 % | 8.94 % | 6.83 % | 9.52 % | 9.42 % | 12.05 % | 13.14 % | 16.13 % | 23.37 % | 20.30 % | 20.12 % | 17.03 % | 16.06 % |
| FCF margin (%) | -0.34 % | 3.11 % | 6.08 % | 2.96 % | 4.43 % | 5.01 % | 5.00 % | 5.77 % | 3.26 % | 8.29 % | 10.71 % | 13.09 % | 13.89 % | 11.68 % | 15.22 % | 14.05 % | 9.55 % | 15.25 % |
